MXCT · NASDAQ · Biotechnology

MaxCyte

Supplies ExPERT electroporation tools, consumables, licenses, and gene-editing assay services.

$1.21
After-hours close−0.01 (−1.02%)
At close$1.23(−4.30%)

Breakdown13F · Form 4

Institutions 60.86%65.20M sharesInsiders 2.20%2.35M sharesOther 36.94%39.57M shares

Shares outstanding 107.12M · Float 97.63M · 91.1% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.8.80M8.21%13FMay 13, 2026
Capricorn Fund Managers Ltd8.20M7.65%13FApr 24, 2026
Vitruvian Partners LLP5.04M4.71%13FMay 11, 2026
Vanguard Capital Management LLC3.98M3.72%13FMay 15, 2026
Morgan Stanley3.69M3.44%13FMay 15, 2026

Institutions13F, as of Mar 31, 2026

131 holders · 65.20M shares · 39 new positions · 69 increased · 36 reduced · 20 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.8.80M8.21%−444.1KMay 13, 2026
Capricorn Fund Managers Ltd8.20M7.65%+8.20MnewApr 24, 2026
Vitruvian Partners LLP5.04M4.71%0May 11, 2026
Vanguard Capital Management LLC3.98M3.72%+3.98MnewMay 15, 2026
Morgan Stanley3.69M3.44%−745.6KMay 15, 2026
Mudita Advisors LLP3.37M3.15%0May 14, 2026
BNP Paribas Asset Management Holding S.A.2.77M2.59%0May 14, 2026
Geode Capital Management, LLC2.36M2.21%−155.6KMay 15, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Capricorn Fund Managers Ltd7.70%8.20M13GFeb 5, 2026
BlackRock, Inc.6.60%7.00M13GJan 21, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Maher Masouddirector, officer: President and CEO475.0K0.44%Mar 31, 2026
Stanley C. Erckdirector428.7K0.40%Jun 22, 2026
Richard Douglasdirector261.0K0.24%Jun 22, 2026
John Joseph Johnstondirector201.6K0.19%Jun 22, 2026
Parmeet Ahujaofficer: Chief Financial Officer187.5K0.18%Apr 17, 2026
William W. Brookedirector181.3K0.17%Jun 22, 2026
Douglas J. Swirskyofficer: CHIEF FINANCIAL OFFICER151.7K0.14%Mar 19, 2026
Cynthia Collinsdirector111.3K0.10%Jun 22, 2026
Yasir B. Al-Wakeeldirector81.0K0.08%Jun 22, 2026
Patrick J. Balthropdirector81.0K0.08%Jun 22, 2026

1 ten-percent owner holds 10.00M shares by Form 4, outside the officers-and-directors figure above · 6 people have not refiled in the last 18 months (10.99M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Mar 17, 2026
Douglas J. Swirskyofficer: CHIEF FINANCIAL OFFICER
Sale10,142$0.8150151,669

CongressHouse and Senate disclosures

Not reported.